A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

NCT03382639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Luvadaxistat
DRUG: Placebo

Sponsor

Neurocrine Biosciences

Collaborators

[object Object]